U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259226) titled 'Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers' on Sept. 26.
Brief Summary: International study that will evaluate the association of prespecified biomarkers with resistance to Antibody-drug conjugates (ADCs), a type of targeted cancer treatment currently used in clinical practice for treating different tumor types.
Study Start Date: Nov. 14
Study Type: INTERVENTIONAL
Condition:
Advanced Breast Cancer
Advanced Gastric Cancer
Advanced Urothelial Cancer
Advanced Non Small Cell Lung Cancer (NSCLC)
Intervention:
PROCEDURE: Biological samples collection
Biological samples co...